Arkuda Therapeutics, a biotechnology company applying new insights into lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease, announced that Gerhard Koenig, PhD, Co-Founder, President and CEO of Arkuda Therapeutics, will present at Stifel’s 3rd Annual CNS Day on Thursday, April 1, 2021 at 1:00 p.m. ET.
March 25, 2021
· 1 min read